Matthew S. Block, M.D., Ph.D.
Mayo Clinic
4
4
3
N/A
0
6
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+4 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Emese Zsiros
Roswell Park Cancer Institute
Shared therapeutic areas:
Worked with same sponsors:
Sharon Manne
Rutgers Cancer Institute of New Jersey
Shared therapeutic areas:
Worked with same sponsors:
Russell Schilder
Gynecologic Oncology Group
Shared therapeutic areas:
Worked with same sponsors:
Rodabe N Amaria
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Lupe Salazar
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Shared therapeutic areas:
Worked with same sponsors:
Aung Naing, Md
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Siqing Fu, MD, PhD
M.D. Anderson Cancer Center
Shared therapeutic areas:
David Spiegel
Stanford University
Shared therapeutic areas:
Worked with same sponsors:
Joanne Mortimer
City of Hope Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Hannah Linden
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Vemurafenib, Cobimetinib, Atezolizumab, and Tiragolumab in Treating Patients With High-Risk Stage III Melanoma
Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable Melanoma
Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
All 4 trials loaded